Jazz Pharma PLC Live Stock Price Today, Share Analysis and Chart

Name: Jazz Pharmaceuticals plc: Is Infosys Ltd. worth buying?
Item: Jazz Pharmaceuticals plc
Rating: 1.900763875
Author: Trendlyne DVM scores

Momentum Trap

about

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav...

247.53 5.35 (2.21%)

Near 52W High of $250.49

503.4K

XNAS Volume

XNAS 17 Jul, 2026 4:14 PM (EDT)

Board Meeting

The next board meeting for Jazz Pharma PLC is on 24 Jul 2026 for the purpose of Jazz Pharmaceuticals PLC Annual General Meeting for 2026 See details

Low Financial Strength

22.2 / 100

Mid Valuation

46.7 / 100

Technically Moderately Bullish

61.0 / 100

Momentum Trap These stocks have average financials but are currently seeing momentum. Investors should exercise caution in buying these stocks View Similar Embed DVM

260

1Yr Price target upside is 5%

19 analysts

Jazz Pharma PLC Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Jazz Pharma PLC Live Stock Price Today, Share Analysis and Chart

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav...

Near 52W High of $250.49

SWOT Analysis

Jazz Pharma PLC Live Price Chart

Jazz Pharma PLC Live Price Chart